These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3887689)

  • 41. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
    Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
    Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Allogenic corneal grafts in inbred strains of rats. IV. Significance of the degree of histoincompatibility between donor and recipient (author's transl)].
    Gronemeyer U; Müller-Ruchholtz W
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1974; 190(4):309-17. PubMed ID: 4611259
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterotopic corneal grafting in mice: a new approach to the study of corneal alloimmunity.
    Streilein JW; McCulley J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1982 Oct; 23(4):489-500. PubMed ID: 6749749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants.
    Zhu SN; Yamada J; Streilein JW; Dana MR
    Transplantation; 2000 Mar; 69(5):1008-13. PubMed ID: 10755569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of oral immunization on corneal allograft survival.
    He YG; Mellon J; Niederkorn JY
    Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1996; 42(3):105-11. PubMed ID: 8971221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts.
    Boulanger A; Asselin I; Roy R; Tremblay JP
    Transplantation; 1997 Mar; 63(6):893-9. PubMed ID: 9089231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergism between minor and major histocompatibility antigens in the rejection of cultured allografts.
    La Rosa FG; Talmage DW
    Transplantation; 1985 May; 39(5):480-5. PubMed ID: 3992648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants.
    Faustman D; Hauptfeld V; Lacy P; Davie J
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5156-9. PubMed ID: 6795629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
    Vallera DA; Taylor PA; Sprent J; Blazar BR
    Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex.
    McKenzie IF; Snell GD
    J Exp Med; 1973 Jul; 138(1):259-77. PubMed ID: 4123828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ABO Blood groups and corneal transplantation.
    Allansmith MR; Drell DW; Kajiyama G; Fine M
    Am J Ophthalmol; 1975 Mar; 79(3):493-501. PubMed ID: 1092175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
    Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
    J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients.
    Fouladi N; Parker M; Kennedy V; Binley K; McCloskey L; Loader J; Kelleher M; Mitrophanous KA; Stout JT; Ellis S
    Hum Gene Ther; 2018 Jun; 29(6):687-698. PubMed ID: 29361840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.